|
|
|
Volumn 6, Issue 11, 2008, Pages 6-8
|
|
New agents for the treatment of AML recent study findings.
a
a
NONE
|
|
Author keywords
[No Author keywords available]
|
|
Indexed keywords
1,2 BIS(METHYLSULFONYL) 1 (2 CHLOROETHYL) 2 ((2 METHYLAMINO)CARBONYL)HYDRAZINE;
1,2-BIS(METHYLSULFONYL)-1-(2-CHLOROETHYL)-2-((2-METHYLAMINO)CARBONYL)HYDRAZINE;
4'-N-BENZOYLSTAUROSPORINE;
5 AZA 2' DEOXYCYTIDINE;
ADENINE NUCLEOTIDE;
ANTINEOPLASTIC AGENT;
ARABINONUCLEOSIDE;
AZACITIDINE;
CARBAZOLE DERIVATIVE;
CLOFARABINE;
DRUG DERIVATIVE;
ENZYME INHIBITOR;
HYDRAZINE DERIVATIVE;
LENALIDOMIDE;
LESTAURTINIB;
MIDOSTAURIN;
QUINOLONE DERIVATIVE;
STAUROSPORINE;
SULFONAMIDE;
THALIDOMIDE;
TIPIFARNIB;
ACUTE GRANULOCYTIC LEUKEMIA;
ARTICLE;
HUMAN;
IMMUNOTHERAPY;
ADENINE NUCLEOTIDES;
ANTINEOPLASTIC AGENTS;
ARABINONUCLEOSIDES;
AZACITIDINE;
CARBAZOLES;
ENZYME INHIBITORS;
HUMANS;
HYDRAZINES;
IMMUNOTHERAPY;
LEUKEMIA, MYELOID, ACUTE;
QUINOLONES;
STAUROSPORINE;
SULFONAMIDES;
THALIDOMIDE;
|
|
EID: 61449227475
PISSN: 15430790
EISSN: None
Source Type: Journal
DOI: None Document Type: Article |
|
Times cited : (6)
|
|
References (0)
|
